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Crude oil exposures reveal roles 
for intracellular calcium cycling in 
haddock craniofacial and cardiac 
development
Elin Sørhus1,2, John P. Incardona3, Ørjan Karlsen4, Tiffany Linbo3, Lisbet Sørensen1,5, 
Trond Nordtug6, Terje van der Meeren4, Anders Thorsen1, Maja Thorbjørnsen5, 
Sissel Jentoft2,7, Rolf B. Edvardsen1 & Sonnich Meier1
Recent studies have shown that crude oil exposure affects cardiac development in fish by 
disrupting excitation-contraction (EC) coupling. We previously found that eggs of Atlantic haddock 
(Melanogrammus aeglefinus) bind dispersed oil droplets, potentially leading to more profound toxic 
effects from uptake of polycyclic aromatic hydrocarbons (PAHs). Using lower concentrations of 
dispersed crude oil (0.7–7 μg/L ∑PAH), here we exposed a broader range of developmental stages over 
both short and prolonged durations. We quantified effects on cardiac function and morphogenesis, 
characterized novel craniofacial defects, and examined the expression of genes encoding potential 
targets underlying cardiac and craniofacial defects. Because of oil droplet binding, a 24-hr exposure was 
sufficient to create severe cardiac and craniofacial abnormalities. The specific nature of the craniofacial 
abnormalities suggests that crude oil may target common craniofacial and cardiac precursor cells either 
directly or indirectly by affecting ion channels and intracellular calcium in particular. Furthermore, 
down-regulation of genes encoding specific components of the EC coupling machinery suggests that 
crude oil disrupts excitation-transcription coupling or normal feedback regulation of ion channels 
blocked by PAHs. These data support a unifying hypothesis whereby depletion of intracellular calcium 
pools by crude oil-derived PAHs disrupts several pathways critical for organogenesis in fish.
Oil spills in critical fish spawning habitats or aquaculture areas are a recurrent worldwide problem1–4. Expansion 
of oil production in Northern Norway has been proposed for the Lofoten and Vesterålen regions, which are also 
crucial spawning and nursing grounds for three of the most important commercial fish species in the North 
Atlantic, including Atlantic haddock (Melanogrammus aeglefinus), cod (Gadus morhua) and herring (Clupea 
harengus)5. Consequently, there is considerable political and public debate with respect to adverse impacts on 
these areas from either accidental oil spills or chronic exposure to operational discharges from oil platforms5–9. 
A baseline understanding of crude oil toxicity to these species is essential for regulatory decision making, spill 
response planning, and environmental risk assessment of oil production impacts in spawning and nursery hab-
itats. We recently identified a unique susceptibility of haddock embryos to toxicity from dispersed crude oil10. 
Unlike other species studied to date, the haddock eggshell (chorion) binds oil droplets, enhancing exposure to 
toxic compounds within crude oil.
Crude oil is a complex chemical mixture containing hundreds of thousands of different compounds. However, 
polycyclic aromatic hydrocarbons (PAHs) and their alkylated homologues are believed to be the main bioavail-
able components that are toxic to developing fish11,12. Multiple lines of evidence accumulated over the last two 
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decades indicate that tricyclic subclasses of PAHs disrupt cardiac function, leading to developmental defects 
in the hearts of exposed embryos11,13,14. There are several mechanisms by which these PAHs may impact heart 
development. First, some PAHs activate the aryl hydrocarbon receptor (AhR), which is central to the metabolic 
detoxification of PAHs as the primary transcriptional activator for PAH–degrading enzymes such as cytochrome 
P4501A (Cyp1a). Despite this protective role, activation of AhR in the developing heart by some PAHs15,16 and 
other potent agonists such as dioxins and PCBs disrupts normal cardiac morphogenesis17–19. In these cases, acti-
vation of AhR2 specifically in cardiomyocytes is necessary and sufficient for induction of all toxicity phenotypes, 
including secondary responses such as jaw malformation18. However, water soluble fractions of crude oil typi-
cally lack PAHs that cause AhR-dependent cardiotoxicity, such as benzo(a)pyrene, and induce heart deformities 
through a second mechanism that is both AhR-independent20–22 and for which Cyp1a metabolism is entirely 
protective23. Studies encompassing crude oils from several sources, individual PAHs, and multiple fish species 
indicate a common cardiotoxic response in exposed embryos that includes defects in contractility and heart rate 
and rhythm13,14,20–22,24–27. In particular, these and other studies11,28,29 have linked this cardiotoxicity of crude oil to 
tricyclic families of PAHs, independent of crude oil source. Single compound studies showed that representatives 
of the most abundant tricyclic PAHs in crude oils mimic human pharmaceuticals with well known ion channel 
blocking activity, such as terfenadine30, consequently producing a chemical phenocopy of mutations in key ion 
channels regulating heart rate and rhythm13,20,30–32.
The cellular basis for serious whole-heart arrhythmia caused by drugs such as terfenadine is the disruption 
of excitation-contraction (EC) coupling33, the process that links electrical excitation of cardiac muscle cells (car-
diomyocytes) to contraction34,35. Ca2+ and K+ ions play central roles in control of the cardiac contraction cycle. 
Membrane depolarization by action potentials opens L-type Ca2+ channels (Ltcc), resulting in extracellular Ca2+ 
entry and a subsequent internal release of Ca2+ from the sarcoplasmic reticulum through the ryanodine receptor 
(RyR). Elevated intracellular Ca2+ activates contractile actin/myosin filaments, causing cardiomyocyte contrac-
tion. Baseline levels of intracellular Ca2+ and K+ ions are then restored by the action of pumps and exchang-
ers such as sarcoplasmic-endoplasmic reticulum calcium ATPase 2 (Serca2) and sodium/calcium exchanger 1 
(Ncx1), and voltage-gated K+ channels such as Erg (encoded by kcnh2)34,35. Compounds that block Erg (e.g., 
terfenadine) prolong action potentials, leading to reduced heart rate (bradycardia) and arrhythmia30, while dis-
ruption of Ca2+ cycling leads to reduced contractility36. Both of these effects were observed in isolated fish cardio-
myocytes following crude oil exposure in a manner that was dependent on the concentration of tricyclic PAHs24. 
Therefore crude oil exposure leads to blockade of both Erg channels and intracellular Ca2+ cycling mediated by 
RyR or Serca224, thus providing an AhR-independent mechanism explaining the whole heart effects observed in 
exposed embryos (e.g. refs 14 and 27).
Ion channels are typically composed of complex heteromultimeric proteins. The role for gene transcription 
in homeostatic regulation of channel biosynthesis is not well characterized37. Ion channel homeostasis theo-
retically involves both cognate (self) regulation of an affected channel at multiple levels (e.g., transcriptional, 
post-transcriptional, and multimer assembly), or compensatory regulation through other ion channels func-
tioning in the same pathway (e.g., EC coupling)37. However, pharmacological blockers of voltage-gated sodium 
channels and pacemaker channels have been shown to increase the expression of the cognate channel genes38,39. 
Thus, a transcriptional response might be expected for genes encoding those EC- coupling channels that are 
blocked by oil exposure.
The developing fish heart acquires functional pumping activity very early during its complex morphogenesis. 
Because cardiac form and function are tightly intertwined, defects in cardiac function at early developmental 
stages can profoundly influence subsequent morphogenetic steps40. The fish heart develops from a simple tube 
that is segmented into two chambers, the atrium and ventricle, which subsequently “loop” to adopt a side-by-side 
orientation. The early contractile heart tube is formed from mesodermally-derived cardiomyocytes arising from 
the first heart field. As the heart tube expands, cardiomyocytes and cells contributing to the outflow tract are 
added from two other sources, the mesodermal second heart field and neural crest cells that migrate from the 
neural tube41,42. In zebrafish (Danio rerio), abnormal looping and ventricular development are associated with 
genetic defects in both EC coupling and contractile function. For example, normal intracellular Ca2+ levels are 
necessary for cardiomyocyte proliferation36,43, while reduced atrial contractility leads to altered ventricular mor-
phology44. Finally, activation of AhR in ventricular cardiomyocytes reduces their proliferation18,45. Therefore, 
there are several routes by which the molecular targets of crude oil can impinge upon cardiac morphogenesis.
We previously demonstrated that Atlantic haddock embryos were unusually susceptible to relatively low levels 
of dispersed crude oil (3 μg/L ∑PAH), due in part to oil droplet binding to the eggshell10. However, in that study, 
the animals were exposed relatively late in development, after organogenesis and the major steps of heart forma-
tion (e.g., looping). The severe effects observed with this late exposure suggest that earlier exposure would have 
even more profound consequences. Moreover, for purposes of risk assessment, toxicity information is needed 
for a broader range of developmental time points. To address these data gaps we exposed haddock to very low 
concentrations of dispersed crude oil (60–600 μg oil/l = 0.7–7 μg/L ∑PAH). Continuous exposure began shortly 
after fertilization and ended 3 days before hatch. We also conducted transient 24- and 48-hr exposures over the 
third and fourth days of embryogenesis, prior to development of a functional heart. As in our previous study, we 
also included an intermittent or pulsed exposure, because it is possible that in an actual spill fish eggs and larvae 
might experience short-term repetitive exposure as result of transport in and out of high oil concentration areas. 
Lastly, we exposed larvae from shortly after hatch to 18 days post-hatch. For both embryos and larvae, we quan-
tified effects on cardiac function and morphogenesis. The visible injury phenotype was then compared to the 
expression of genes encoding potential molecular targets of PAHs in EC coupling to further characterize potential 
mechanisms of crude oil cardiotoxicity and novel craniofacial abnormalities.
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Results
Eggshell oil droplet accumulation and differential PAH uptake in embryos and larvae. Total 
PAHs (dissolved and droplet-associated) were measured in water at the start of exposure. For the low and high 
dose treatments, ∑PAH was 0.58 ± 0.05 μg/L and 6.7 ± 0.2 μg/L, respectively. The pulse dose peak concentration 
was the same as high, as expected, at 6.8 ± 1.0 μg/L measured at the maximum of the 2.4 hour pulse, and 
returned to background levels (0.09 ± 0.02 μg/L) between pulses. ∑PAH concentration in the control tanks was 
0.03 ± 0.01 μg/L. For the larval exposure, low and high dose treatments had 0.65 ± 0.08 μg/L and 7.6 ± 0.7 μg/L, 
respectively. The pulse exposure had a peak concentration of 6.1 ± 0.5 μg/L, with a low concentration of 
0.3 ± 0.3 μg/L between pulses. Control tanks in the larval exposure had ∑PAH concentrations of 0.03 ± 0.01 μg/L. 
The PAH profile in the exposure tanks was dominated by the C0-C3 naphthalenes (~60%), followed by the tricyclic 
PAHs which contributed ~39% of the total PAHs (Supplementary Fig. S1, Supplementary Table S1).
The adherence of oil microdroplets to the eggshell was evident microscopically within 24 hours of embryonic 
exposure, and this increased over time (Supplementary Fig. S2). Fluorescence from oil-associated compounds 
such as PAHs showed that by 10 dpf droplets coalesced nearly into a sheet covering the eggshell (Fig. 1A) in a 
concentration-dependent manner (Fig. 1B).
Tissue concentrations of PAHs in embryos and larvae were determined at the end of each exposure. These were 
higher for all treatments with embryos relative to those with larvae (Fig. 2). Embryos accumulated ∑PAH con-
centrations (ng/g wet weight ± SD) of 27 ± 10, 192 ± 17, 218 ± 64, and 2961 ± 1258 and larvae accumulated 5 ± 1, 
86 ± 15, 81 ± 24, 808 ± 184 ng/g ∑PAH in control, low, pulse and high dose treatments, respectively. Although 
the higher levels of embryo-associated PAHs were evidently due in part to whole oil coating the eggshell, it was 
not possible to differentiate between this fraction and the PAH fraction that was bioavailable to haddock embryos 
within these ∑PAH measures. Embryos from one low dose and pulse dose tank (L3 and P1, respectively) had 
lower ∑PAH concentrations than the other replicates, and both were closer to each other. Embryos in the L3 tank 
had ∑PAH levels of 226 μg/g compared to 274 ± 15 (mean ± SD) for the other replicates, while embryos from the 
Figure 1. PAH-associated fluorescence. (A) 10 dpf embryos (last day of exposure) in transmitted light (first 
panel) and PAH-associated fluorescence as black and white (second panel). (B) measured light intensity in 
control, low, pulse and high dose at 6 dpf and 10 dpf. Statistical significant difference between groups (p < 0.05) 
is indicated with letters, (i.e., groups with same letters are not significantly different from each other).
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P1 tank had ∑PAH of 188 μg/g compared to 376 ± 93 for the other pulse treatment replicates. As indicated below 
and in Supplementary Fig. S3, fish from these two tanks displayed correspondingly reduced toxicity.
Temporal and tissue expression patterns of cyp1a induction in relation to exposure. We meas-
ured the effective response to tissue uptake of PAHs using quantitative PCR (qPCR) for cyp1a mRNA in pooled 
samples. Two-way ANOVA showed significant effect of time, dose and time-dose interaction for both embryonic 
and larval exposure (Table S2). Remarkably, cyp1a induction was evident within 24 hours of exposure in the 
high dose group when embryos were starting gastrulation (~50% epiboly) (p = <0.0001). Expression of cyp1a 
increased during exposure with a plateau at 8 dpf of roughly 50-, 70- and 180-fold in low, pulse and high dose 
treatments (p < 0.0001), respectively. One day after transfer to clean water, but prior to the onset of hatching 
(11 dpf), cyp1a expression remained at plateau levels in each exposed group (p < 0.0001). However, after initia-
tion of hatching cyp1a expression in exposed animals dropped to control levels (Supplementary Fig. S4). In the 
embryonic exposure, the L3 (low dose) and P1 (pulse dose) replicates showed 5-times lower cyp1a expression 
relative to the other 3 tanks receiving the same dose at all sampling points during exposure, and also showed 
lower frequencies of toxicity-related effects (see below), consistent with reduced exposure to oil. Although a 
Grubbs’ test of individual cyp1a or ∑PAH data from 10 dpf (final day of exposure) was inconsistent with these 
points being outliers, plotting cyp1a levels against ∑PAH concentrations indicated that these two tanks can be 
considered a separate, lower dose (Supplementary Fig. S3). The lower biological response during the whole time 
series indicates that these two replicates received a lower internal dose. This may not be reflected in the measured 
tissue PAHs, which includes biologically unavailable material on the outer eggshell. Therefore, we excluded data 
from those tanks in statistical analyses of exposure and effects endpoints below. Compared to haddock exposed 
as embryos, cyp1a was rapidly induced in larvae and maintained at a significantly lower (p < 0.0001) but relatively 
constant level, roughly 8-, 13- and 18-fold in low, pulse and high dose, respectively (Supplementary Fig. S4).
As a measure of AhR activation in tissues in relation to toxicity phenotypes, we determined the tissue distribu-
tion of Cyp1a. In the embryonic exposure, we used whole mount immunofluorescence and confocal microscopy 
in newly hatched larvae (11 dpf) (Supplementary Fig. S5). Control larvae showed no Cyp1a labeling, while larvae 
from the low dose group showed low levels of Cyp1a labeling in the epidermis and liver. Larvae from the high 
dose group showed labeling that was visible throughout the epidermal cells and strong in the liver. Remarkably, 
there was little if any Cyp1a protein detected in the heart, either in the endothelial layer or myocardium. No 
Cyp1a labeling was observed in other internal structures besides the liver in exposed larvae.
For the larval exposure, we examined the tissue distribution of cyp1a mRNA by in situ hybridization at 
1 dph and 18 dph. After one day of exposure (1 dph), cyp1a expression was evident in the outer epidermis, liver 
Figure 2. Total measured PAH. (A) Water concentrations of ∑PAH (ug/L) and (B) body burden of ∑PAH in 
embryo and larval exposure at the end of the exposure (10 dpf and 18 dph, respectively).
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hepatocytes, epithelia of the head kidney and intestines, and endothelium of the heart, but notably absent from 
the myocardium (Supplementary Fig. S6). After 18 days of exposure (18 dph) cyp1a expression was maintained 
in the epidermis, heart, kidney, intestines and liver, and new expression was observed in the gall bladder, gills 
and brain. In contrast to 1 dph where cyp1a expression was pronounced in hepatocytes, expression appeared 
to be limited to the sinusoid lining cells at 18 dph (Supplementary Fig. S6). Moreover, at 18 dph, the liver sinu-
soids of oil exposed larvae appeared more dilated in comparison to control larvae, consistent with our previous 
observations10.
Stage-specific craniofacial malformations. Embryonic exposure resulted in a dose-dependent gradient 
of striking craniofacial malformations visible by 3 dph (Fig. 3). These abnormalities were in addition to the per-
icardial/yolk sac edema that is characteristic of crude oil cardiotoxicity (detailed below). Exposure to increasing 
concentrations of oil led to a progressive loss of craniofacial structures, affecting the upper jaw first at the low dose 
(Fig. 3B) and including the lower jaw in the high exposure group (Fig. 3E). Craniofacial malformations consist-
ently fell into four distinct types: isolated underdevelopment of the upper jaw (bulldog, BD); a more severe under-
developed upper jaw with a posteriorly displaced lower jaw (jawbreaker, JB); an underdeveloped upper jaw with 
hanging lower jaw (Darth Vader, DV); and finally, severe reduction of all jaw structures, reduced anterior brain 
structures and poor dorsal rotation of the head conveying a characteristic hunchback appearance (hunchback, 
HB). In addition, all animals with the HB phenotype and many animals with the DV phenotype had dorsal curva-
ture of the body axis and reduction of the posterior finfold. The frequencies of the various phenotypes coincided 
with dose. The most frequent abnormal phenotypes in low dose group were BD and JB (17% and 15%, respec-
tively), the pulse dose was dominated by BD and DV (28% and 27%, respectively), while the high dose group was 
dominated by HB (54%), although BD and DV also were frequent (15% and 23%, respectively) (Fig. 3F). These 
phenotypes also occurred after the transient embryo exposure (24 and 48 hours starting at 2 dpf). The 24-hour 
high dose exposure group had incidences of BD and DV of 7% and 3%, respectively, while the 48-hour high dose 
exposure group had 17% BD, 10% DV, and even a small percentage of HB (3%) (Table 1).
Alcian blue staining at 3 dph confirmed a graded and overlapping series of defects in the cartilaginous pre-
cursors of the craniofacial skeleton (Fig. 4). The head skeleton consists of three basic divisions: the basicranium, 
the jaws and the gill support structures. Cartilages present at this stage in controls included the basicranium, 
comprising the ethmoid plate, trabeculae and parachordal cartilages (Fig. 4A,E), and main jaw cartilages derived 
from the first (Meckel’s and quadrate), and second (hyoid and hyomandibular-symplectic) pharyngeal arches 
(Fig. 4A,E). While the posterior pharyngeal arches produce five ceratobranchials, only three were visible by 
Alcian blue staining at this stage (Fig. 4). In the milder “short face” or BD phenotypes all cartilages were present, 
but they were generally reduced in length (Fig. 4B). After Alcian blue staining, it was difficult to distinguish 
between DV and JB animals. However, these phenotypes were both characterized by presence of the main jaw 
cartilages derived from the first and second pharyngeal arches, with distortion of Meckel’s cartilage that varied 
in severity, but generally was marked by inversion across the anterior-posterior axis (Fig. 4C,F). In addition, cer-
atobranchials other than cb1 were typically absent (Fig. 4F), and the basicranium often was reduced to a degree 
that seemed disproportionate to the reductions of the first and second arch derivatives. In the most severe cases 
(HB), the basicranium was completely lacking, and the first and second arch derivatives were markedly smaller 
with the quadrate lacking (Fig. 4D,G), and only the first ceratobranchial was present (Fig. 4G). In addition to the 
anterior-posterior inversion, the misshapen appearance of Meckel’s cartilage suggested that the quadrate may not 
be simply absent, but fused with Meckel’s cartilage (Fig. 4G).
In addition to jaw malformations, some animals appeared to have more closely spaced eyes (hypotelorism) 
and a failure to close the choroid fissure (coloboma) (Supplementary Fig. S7). We quantified eye spacing in ven-
trally positioned larvae at 0 dph. Although all exposed groups showed hypotelorism, this effect was more severe 
in the low dose group (26% reduction in eye spacing), than both high and pulse groups (14% reduction; Table 1). 
Because of time limitations related to collection of cardiac function data, we did not collect the types of images 
necessary for rigorously quantifying the occurrence of coloboma.
Haddock exposed as larvae did not show same the severe phenotypes that were evident following embry-
onic exposure. After two days of exposure the ethmoid plate was significantly shortened in the high dose group 
(Supplementary Fig. S8). Shortening of the ethmoid plate was significant and dose-dependent in all groups after 
9 days of exposure (9 dph), with lengths of 197-, 199- and 170 μm in low, pulse and high dose, respectively, com-
pared to 219 μm in control (Supplementary Fig. S8 and Table 2). After 18 days of exposure (18 dph) the high dose 
group showed continued reduction of the ethmoid plate at 48% of control (Table 2). To determine if the ethmoid 
plate was selectively reduced or simply reflective of a smaller total skull size, we measured the mandible and used 
the ethmoid plate/mandible (EP/M) ratio. The mandible also was significantly reduced in the high dose group 
at 2, 9 and 18 dph, in pulse dose group at 9 and 18 dph and in low dose at 2 and 9 dph. However, the EP/M ratio 
showed that ethmoid plate shortening was greater than shortening of other craniofacial structures in the high 
dose group at 9 and 18 dph, and in pulse group at 18 dph (Table 2).
Distinct cardiotoxic effects in embryonic and larval exposures. As expected from previous studies 
in other species, haddock embryos displayed dose-dependent edema in response to continuous embryonic oil 
exposure after only 7 days (Table 3). Edema accumulated in both the yolk sac sinus and pericardial space. By 
hatching stage (13 dpf/0 dph), edema spread more extensively throughout the yolk sac. The percent of area occu-
pied by edema fluid was significantly higher in the low dose group (15%) and the pulse and high dose groups 
(both 31%) compared to control (7%) (Table 3). Surprisingly, occurrence and severity of edema did not correlate 
exactly with severity of craniofacial phenotype. For example, exposed animals with either normal or BD crani-
ofacial phenotype sometimes had more edema than animals with JB phenotype. Similarly, larvae with DV phe-
notype had higher occurrence and more severe edema than those with HB phenotype (Supplementary Fig. S9). 
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Figure 3. Craniofacial phenotypes following embryonic exposure. (A) Control and (B–E) exposed animals 
at 3 dph (6 days post exposure stop). Craniofacial malformations fell into four distinct phenotypes: (B,B’, higher 
magnification) bulldog phenotype, BD, (C,C’) jaw breaker, JB (D,D’) Darth Vader, DV and (E,E’) hunchback, 
HB. Filled arrows indicate livers and guts appearing to be grossly normal in comparison to craniofacial and 
cardiac abnormalities. Filled arrow in C’ indicates coloboma. (F) Distribution of structural phenotypes with 
percentage of animals with no abnormal phenotypes = none, BD, JB, DV and HB phenotype for control = C, 
low = L, pulse = P and high = H doses). Scale bar 1 mm.
www.nature.com/scientificreports/
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In the transient embryo exposure, edema was evident only in embryos exposed to the high dose for 48 hours (17% 
compared to 10% in controls, Table 3).
Because edema is a sign of reduced cardiac output, we assessed cardiac function with digital video. Bradycardia 
(reduced heart rate) was observed in animals from the continuous embryo exposure, both during exposure (at 
9 dpf) and after exposure (0 dph and 3 dph) (Table 3). In addition some exposed embryos also displayed con-
tinuous ventricular asystole (silent ventricle) as early as 9 dpf in a dose-dependent manner, with continuously 
exposed groups showing 13%, 30%, 54% in low, pulse and high dose, respectively, compared to 5% in control at 
0 dph (Table 3). With further development, the fraction of silent ventricles increased so that at 3 dph frequencies 
were 57%, 29% and 72% in low, pulse and high dose, respectively, compared to 2% in control. Remarkably, ani-
mals from both transient exposures also had silent ventricles, with an incidence of 20% in the 24-hour high dose 
exposure (Supplementary Video S1), and 17%, 7% and 23% in the 48-hour low, pulse and high dose exposures, 
respectively. In contrast to the continuous exposure, however, transiently exposed embryos did not show brady-
cardia (Table 3).
As a consequence of the high frequency of silent ventricles, ventricular contractility (fractional shortening, see 
Methods) at 0 dph was significantly reduced in pulse and high dose, while atrial contractility was solely reduced in 
the high dose group. By 3 dph the low dose group also had significant occurrence of silent ventricle, thus reducing 
the contractility measure (Table 3, shown graphically in Supplementary Fig. S10). Because silent ventricles have 
a fractional shortening measure of zero, this skews the mean measure for the whole group. Elimination of meas-
urements from silent ventricles showed that animals with functional ventricles in low and high dose groups still 
had significantly reduced ventricular contractility.
Animals with severely reduced cardiac function often had ventricles that appeared markedly underdeveloped. 
To quantify ventricular form and determine if there were more subtle perturbations in cardiac morphology, we 
measured the area, length and curvature (as circularity) of the ventricle (Fig. 5E). These measures allowed an 
assessment of the size and three-dimensional orientation (looping). Animals with HB and DV phenotypes had 
the most severely impacted cardiac morphology, resulting in a dose-dependent decrease in ventricular length, 
area and circularity (Table 3). While the low dose group had significantly reduced ventricular area and length, the 
circularity was not significantly different from control, suggesting an effect on ventricular growth but not looping 
(Table 3).
Larval exposure also resulted in edema, but produced different cardiac function phenotypes. Edema accumu-
lated in the pericardial compartment as well as the peritoneal cavity as true ascites, and in the dorsal subdermal 
space of the head (Fig. 6). After 9 days of larval exposure (9 dph), we observed significantly increased edema area 
of 12, 12 and 13% in low, pulse and high dose, respectively, compared to 9% in control (Table 3). After 18 days of 
exposure (18 dph), edema was significantly elevated only in the high dose group (32% compared to 7% in control) 
(Table 3). In addition to the severe edema found in the high dose larvae at 18 dph, the liver often appeared opaque, 
an indication of liver toxicity15 (Fig. 6).
No changes in larval cardiac function were detected after only 2 days of exposure, but were measureable at 
9 days (Table 3). As opposed to the bradycardia observed in embryos, there was a trend towards tachycardia 
(increased heart rate) (Table 3). We also detected a distinct rhythm abnormality in the form of the heartbeat, 
bypassing of ventricle, indicative of atrioventricular (AV) conduction block (Table 3, Supplementary Fig. S10, 
Supplementary Video S2). This ventricular arrhythmia was observed in all exposed groups and was most fre-
quent in the high dose. The arrhythmia ranged from intermittent and random skips of ventricular contraction 
Exposure STAGE Group BD1, % JB, % DV, % HB, % BE % of control
Transient exposure
24 h, 2 dph (13 dpe2)
Control 0 0 0 0 —
Low dose 0 0 0 0 —
Pulse dose 0 0 0 0 —
High dose 7 0 3 0 —
48 h, 2 dph (12 dpe)
Control 0 0 0 0 —
Low dose 0 0 0 0 —
Pulse dose 0 0 0 0 —
High dose 17 0 10 3 —
Continuous embryonic exposure
E0 dph (3 dpe)
Control — — — — 100 ± 21a
Low dose — — — — 74 ± 23b
Pulse dose — — — — 86 ± 13c
High dose — — — — 86 ± 16c
3 dph (6 dpe)
Control 1 ± 3a 0a 0a 0a —
Low dose 17 ± 7b 15 ± 18b 2 ± 3b 0a —
Pulse dose 28 ± 8c 2 ± 3a,c 27 ± 19c 0a —
High dose 15 ± 9b 4 ± 5c 23 ± 10c 54 ± 19b —
Table 1.  Craniofacial phenotypes after transient and continuous embryonic exposure. 1BD, bulldog; JB, jaw 
breaker; DV, Darth Vader; HB, hunchback; BE, distance between eyes. a–dLetters indicate significant differences 
between groups (p = <0.05) (groups with same letters are not significantly different from each other). 
2Dpe = days post exposure stop.
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Figure 4. Alcian blue staining of 3 dph embryonically exposed larvae. (A,E) show a lateral and dorsal view of 
a control larva, respectively. (B–D) and (F–G) show the lateral and dorsal views of exposed larvae, respectively. 
t/ep = trabeculae crania/ ethmoid plate, pch = parachordal cartilages, m = Meckel’s cartilage, q = quadrate, 
hs = hyomandibular symplectic pharyngeal arches, hy = hyoid pharyngeal arches, cb = ceratobranchial Asterisk 
in (D) indicates absent basicranial cartilages Scale bar 0.5 mm.
www.nature.com/scientificreports/
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(asystole) to a regular 2:1 partial AV block (i.e., skipping every other ventricular contraction). Silent ventricle 
was not observed in the larval exposure. In contrast to the embryonic exposure, ventricular fractional shortening 
was increased in the high dose group after 9 days of exposure, 21% compared to 17% in control, probably due to 
increased filling in animals with AV block.
Relationship of phenotypes to gene expression. The observed craniofacial and cardiac phenotypes 
suggest several candidate target genes whose expression level might be perturbed by oil exposure. Based both on 
the known potassium and calcium channel ion blocking activity of crude oil24 and the cardiac function defects 
observed here, we selected several EC coupling genes, including ncx1 (sodium/calcium exchanger 1 (Ncx1)), 
cacna1c (voltage-dependent L-type calcium channel (Ltcc)), kcnh2 (potassium voltage-gated channel subfamily 
H member 2 (Erg)), serca2 (sarcoplasmic-endoplasmic reticulum calcium ATPase (Serca2))34 as well as a gene 
that may be involved in both craniofacial and cardiac defects (wnt11 (wingless-type MMTV integration site fam-
ily, member 11)46,47). Gene expression was measured by qPCR in both pools and in individual larvae with known 
phenotypes. In the embryonic exposure a significant effect of both dose and time and a time-dose interaction 
were observed only for kcnh2 (Table S2). Dunnet’s post hoc test showed significantly reduced expression in the 
high dose group at 11 dpf (1 day post-exposure) (p = <0.0001), 0 dph (p = 0.0021) and 3 dph (0.0027) (Fig. 7A). 
On average, individual larvae showed down-regulation of kcnh2 at 3 dph in accordance with cardiac phenotype 
(Fig. 7B). Surprisingly, individuals with silent ventricles and relatively normal morphology did not have reduced 
kcnh2 expression, while those with underdeveloped silent ventricles showed reduced kcnh2 expression (Fig. 7E). 
The alterations in kcnh2 expression were not seen at earlier stages, becoming apparent only after the end of 
organogenesis (Fig. 7A). Expression of ncx1 was significantly lower in high dose individuals at 3 dph (p = 0.0023) 
(Fig. 7D) and was associated with the underdeveloped silent ventricle phenotype (Fig. 7E). However, in the 
pooled samples, although detecting an effect of dose, potentially reflecting the first time point (3 dpf) (Fig. 7C), 
two-way ANOVA did not detect a significant time-dose interaction for ncx1 (Table S2). No significant effects of 
dose were observed for wnt11, cacna1c and serca2.
In contrast to the embryonic exposure, there was no difference in kcnh2 expression in either pooled sam-
ples or individuals in the high dose group of the larval exposure, despite the observed AV block phenotype 
(Supplementary Fig. S12, Fig. 8). For wnt11, the two-way ANOVA showed an effect of dose, but no dose-time 
interaction (Table S2). Expression of wnt11 appeared to be dynamic during early larval development (Fig. 8A). 
While low and pulse dose follow the same dynamic expression for wnt11 as control, the high dose group appeared 
to have lost this regulation and instead showed a trend of overall increased expression at most time-points. This 
observation is consistent with significantly higher (p = 0.0006) levels of wnt11 in individuals at 9 dph (Fig. 8A). 
Further, the high dose group showed a trend of higher cacna1c levels at most time points (1–14 dph), and no 
differences in ncx1 and serca2 levels (Supplementary Fig. S12).
Craniofacial defects are species-specific and not specific to oil source. The unusual craniofacial 
phenotypes observed here could either be a species-specific response of Atlantic haddock, or a novel activity 
associated with the composition of Heidrun crude oil. To make this distinction, we exposed zebrafish embryos to 
50 mg/L dispersed Heidrun oil blend (compared to the haddock high dose of 0.6 mg/L), the same concentration 
tested in zebrafish embryos with other geologically distinct crude oils28,29,48. Although we did not measure PAH 
concentrations in this exposure, we used a standardized method to produce a high-energy water-accommodated 
fraction that was predicted to have ∑PAH in the range of 300–400 μg/L21,22. In contrast to what we observed 
in haddock, the zebrafish phenotypes were consistent with those observed with other crude oils. This level of 
Heidrun blend exposure produced high rates of pericardial edema (black arrow) and intracranial hemorrhage 
(white arrow) at 48 hours post fertilization (hpf) (Supplementary Fig. S13). Notably, these defects occurred at 
similar frequencies as for the same concentrations of crude oils from Alaska, Louisiana, and Iran21,22. Hearts in 
exposed embryos at 48 hpf showed poor looping (asterisk, Supplementary Fig. S13) and as for other crude oils, 
reduced contractility but not AV block arrhythmias (Supplementary Video S3). Importantly, exposed zebrafish at 
Exposure STAGE Group EP3, μm M, μm EP/M, %
Larval exposure
2 dph
Control 135 ± 17a 417 ± 30a 32 ± 4a
Low dose 122 ± 17b,c 395 ± 66b 31 ± 4a
Pulse dose 132 ± 20a,b 411 ± 24a 32 ± 5a
High dose 118 ± 16c 388 ± 28b 30 ± 4a
9 dph
Control 219 ± 21a 586 ± 45a 37 ± 5a
Low dose 197 ± 27b 557 ± 44b 35 ± 5a,b
Pulse dose 199 ± 29b 554 ± 47b 36 ± 5a,b
High dose 170 ± 28c 495 ± 39c 34 ± 5b
18 dph
Control 314 ± 49a 2442 ± 252a 38 ± 5a
Low dose 295 ± 55a,b 2324 ± 262a 37 ± 6a
Pulse dose 263 ± 63b 2216 ± 310b 34 ± 5a
High dose 151 ± 39c 1812 ± 165 c 25 ± 5b
Table 2.  Craniofacial outgrowth in larval exposure. 3EP, ethmoid plate; M, mandible. a–dLetters indicate 
significant differences between groups (p = <0.05) (groups with same letters are not significantly different from 
each other).
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either 48 or 72 hpf did not show the same striking craniofacial phenotypes as haddock, but simply reduced lower 
jaw outgrowth as observed with other crude oils (Supplementary Fig. S13).
Discussion
As expected, we observed more profound effects in haddock embryos when exposed to crude oil just after fertili-
zation compared to exposure relatively late in embryogenesis10. Further, we show that despite a higher metabolic 
capacity, larval haddock are also susceptible toxicity from very low levels of dispersed crude oil. The most remark-
able effect observed here is the dramatic craniofacial malformation following embryonic exposure. However, 
the severity and specificity of the craniofacial phenotypes are inconsistent with a simple secondary response 
to edema. In both the embryonic and larval exposures, we observed defects in cardiac function (heart rate and 
rhythm, contractility) that were detectable before or nearly coincidental with edema accumulation. Many aspects 
of these cardiac function phenotypes were also unexpected and specific to developmental stage. In particular, 
the effect oil exposure had on EC coupling gene expression was contradictory to the transcriptional responses 
to chronic pharmacological blockade previously shown for some ion channels38,39. A key question discussed in 
detail below is whether the craniofacial malformations represent a novel activity of crude oil, or can be explained 
by the known effects of crude oil-derived PAHs on intracellular calcium handling. Finally, these studies highlight 
the unique properties of the haddock eggshell that lead to oil droplet binding. Consequently, PAH uptake is pro-
longed and enhanced, with even very short exposure during early development causing severe defects.
Exposure STAGE Group
Edema 
area, % BPM4 SV, %
VFS, % 
SV incl.
VFS, % SV 
excl. AFS, %
VL % of 
control
VA % of 
control





24 h, 2 dph 
(13 dpe)
Control 8 ± 5a 57 ± 6 0 18 ± 4a 18 ± 4a — — — — 0
Low dose 9 ± 5a 57 ± 7 0 16 ± 5a 16 ± 5a — — — — 0
Pulse dose 10 ± 7a 57 ± 5 0 16 ± 5a 16 ± 5a — — — — 0
High dose 7 ± 4a 56 ± 5 20 9 ± 5b 12 ± 5b — — — — 0
48 h, 2 dph 
(12 dpe)
Control 10 ± 5a 57 ± 8 0 17 ± 4a 17 ± 4a — — — — 0
Low dose 11 ± 7a 59 ± 7 17 13 ± 8a,b 16 ± 6a,b — — — — 0
Pulse dose 9 ± 4a 56 ± 5 7 14 ± 6a 16 ± 5a,b — — — — 0




Control †10 ± 12a 26 ± 3a 2 ± 4a — — — — — — —
Low dose †28 ± 18b 25 ± 5a 14 ± 5b — — — — — — —
Pulse dose †43 ± 32c 26 ± 4a 44 ± 21c — — — — — — —
High dose †70 ± 20d 20 ± 6b 49 ± 15c — — — — — — —
0 dph  
(3 dpe)
Control 7 ± 6a 41 ± 6a 5 ± 5a 17 ± 7a 18 ± 6a 25 ± 6a 100 ± 21a 100 ± 32a 100 ± 5a 0
Low dose 16 ± 9b 42 ± 6a 13 ± 8b 15 ± 7a,b 16 ± 6a 25 ± 7a 89 ± 20b 84 ± 33b 99 ± 4a 0
Pulse dose 31 ± 14c 41 ± 7a 30 ± 15c 12 ± 9b 15 ± 7a 24 ± 6a 64 ± 16c 49 ± 21c 93 ± 6b 0
High dose 31 ± 12c 34 ± 11b 54 ± 28d 4 ± 6c 9 ± 6b* 16 ± 8b 51 ± 21d 35 ± 23d 85 ± 14c 0
3 dph  
(6 dpe)
Control — 59 ± 7a 2 ± 3a 17 ± 6a 17 ± 5a 21 ± 7a — — — 0
Low dose — 59 ± 6a 57 ± 25b 7 ± 7b,d 12 ± 6b 17 ± 7b — — — 0
Pulse dose — 58 ± 8a 29 ± 17c 12 ± 8c 15 ± 6a,c 17 ± 6b — — — 0
High dose — 46 ± 10b 72 ± 20d 3 ± 6d 14 ± 4b,c* 11 ± 7c — — — 0
Larval exposure
2 dph
Control — 73 ± 10a 0 16 ± 4a — — — — — 4 ± 8a
Low dose — 77 ± 7a 0 15 ± 5a — — — — — 2 ± 4a
Pulse dose — 78 ± 10a 0 16 ± 5a — — — — — 2 ± 4a
High dose — 77 ± 11a 0 16 ± 6a — — — — — 2 ± 4a
9 dph
Control 9 ± 3a 105 ± 12a 0 17 ± 3a — — — — — 0 ± 0a
Low dose 12 ± 4b 104 ±19a 0 17 ± 4a — — — — — 2 ± 4a
Pulse dose 12 ± 4b 110 ± 13a 0 17 ± 4a — — — — — 8 ± 7b
High dose 13 ± 4b 106 ± 15a 0 21 ± 4b — — — — — 17 ± 12c
18 dph
Control 7 ± 5a — — — — — — — — —
Low dose 15 ± 16a — — — — — — — — —
Pulse dose 13 ± 11a — — — — — — — — —
High dose 32 ± 13b — — — — — — — — —
Table 3.  Characterization of cardiac function and morphology. 4BPM, beats per minute; SV, silent ventricle; 
VFS, ventriclular fractional shortening; AFS, atrial fractional shortening; VL, ventricular length; VA, ventricular 
area; VC, ventricular circularity; A/V atrioventricular. Dpe = days post exposure stop. a–dLetters indicate 
significant differences between groups (p = <0.05) (groups with same letters are not significantly different from 
each other). VFS measurements were not performed in animals with severely underdeveloped ventricles. 
†Incidence of edema, not area. *Few animals with beating ventricles.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:31058 | DOI: 10.1038/srep31058
Figure 5. Illustration of larval measurements. (A) Measurement of length between eyes (1) and ventricular 
and atrial diastolic and systolic diameter (2 and 3, respectively) at 0 dph and 2 dph (transient embryonic 
exposure only), ventrally positioned. (B) Measurement of ethmoid plate from eye to nose tip (1), measurement 
of ventricular and atrial diastolic and systolic diameter (2 and 3, respectively) at 3 dph and 10 dph, laterally 
positioned and (C) measurement of edema at 0 dph and 2 dph (transient embryonic exposure only). Red line: 
yolk sac area with included edema. Green line: only yolk sac area. (D) Edema measurements in 10 dph and 
19 dph larvae. Red line represents both organ area and edema. Green line represents only organs.  
(E) Ventricular length (yellow line), area (dashed box) and circularity (yellow line) were measured to estimate 
cardiac deformity.
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Cardiotoxic mechanisms in relation to cardiac phenotypes. In the embryonic exposure we observed 
two prominent cardiac phenotypes. In more severely impacted animals (e.g., HB), hearts were underdeveloped 
with silent ventricles. By contrast, animals with less severe gross phenotypes in the transient exposure and low 
dose groups had hearts with silent ventricles that appeared more normally developed. Depending on the exact 
circumstances, silent ventricle could reflect chemical blockade of ion channels, disruption of ion channel biosyn-
thesis, or a defect in cardiac cell differentiation, either singly or in combination. In turn, the altered morphology 
could either be downstream of EC coupling defects or due to a more direct developmental defect. For example, 
the asystolic effect could be due in part to failed development of specialized conduction cells49. As an initial effort 
to make this distinction, we examined the expression of key EC coupling genes encoding likely direct targets of 
PAHs (Erg, Serca2) and other components that could be either contributory or compensatory (Ltcc, Ncx1). Our 
findings suggest at least a dual mechanism that involves ion channel blockade as well as biosynthesis.
An additional mechanism of cardiotoxicity is activation of AhR in heart muscle cells, as has been shown for 
some higher molecular weight PAHs (e.g., benzo[a]pyrene50–52, and the C4-alkylated phenanthrene, retene16). 
However, the role of cardiomyocyte AhR activation in crude oil toxicity is less certain. Studies in zebrafish have 
shown differential activation of AhR in cardiomyocytes depending on the state of weathering20,22, while myocar-
dial Cyp1a induction was observed in Pacific herring (Clupea pallasii) exposed to the same source crude oil14. 
Nevertheless, AhR activation in cardiomyocytes is not required for crude oil cardiotoxicity20–22. Consistent with 
this, here we observed no myocardial induction of Cyp1a in either the embryonic or larval exposure. While we 
did observe endocardial Cyp1a induction in the larval exposure, consistent with prior studies, it was remarkable 
Figure 6. Phenotypes after 18 days of larval exposure. (A) Control and (B–D) exposed larvae (higher 
magnification B’–D’). There was variation in appearance of deformities in all exposed groups, ranging from 
larvae with shortened ethmoid plate and mild edema in (B) to the more extreme cases in (C,D) with jaw 
deformities, severe abdominal (asterisk) and pericardial (red asterisk) edema, shortened ethmoid plate (filled 
arrowheads), subdermal fluid accumulation (open arrow heads) and opaque liver (arrow). Scale bar 1 mm.
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that in the most severely impacted embryos, there was no evidence of AhR activation anywhere in the heart. 
Therefore it is most likely that the effects on heart morphology are directly related to AhR-independent effects on 
EC coupling pathways from PAHs that are poor AhR ligands.
The reduced contractility of both chambers in the embryonic exposure is consistent with defects in intracel-
lular calcium cycling24,36,43. Disruption of intracellular calcium levels also reduces cardiomyocyte proliferation, 
leading to smaller hearts36,43. Alternatively, reduced ventricular size could also result from effects on either cardiac 
neural crest cells or the second heart field. Indeed there is some overlap of cardiac phenotypes between oil expo-
sure and ablation of either the second heart field or neural crest cells, including bradycardia and small ventricle53. 
Figure 7. Expression of genes involved in EC coupling and wnt11 in the embryonic exposure. Expression 
of kcnh2 in (A) pooled samples throughout early development (3 dpf to 3 dph) and (B) individuals at 3 dph 
(6 days post exposure), and ncx1 in (C) pooled samples and (D) individuals. (E) Expression of kcnh2, ncx1, 
cacna1c, serca2 and wnt11 in individuals at 3 dph. Collectively, in individuals only kcnh2 and ncx1 were 
significantly different from control. Statistical significant difference from control is indicated by *p < 0.05 and 
**p < 0.01. Numbers along x-axis refer to cardiac phenotype: 0 = no cardiac abnormalities; 1 = Silent ventricle; 
2 = Underdeveloped ventricle; 3 = Silent ventricle and underdeveloped ventricle; 4 = Silent ventricle and very 
underdeveloped ventricle.
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While we do not have direct cellular evidence for effects on either the second heart field or cardiac neural crest 
cells, the remarkable craniofacial phenotypes potentially implicates direct effects of crude oil on neural crest cells 
in haddock embryos.
The persistence of the silent ventricle phenotype in the low dose group well past the end of exposure, and 
the uncoupling of the phenotype from cyp1a induction provide interesting insight into the complexity of PAH 
toxicokinetics. Remarkably, after 6 days in clean water (3 dph) in the low dose group, the silent ventricle pheno-
type actually occurred at a higher frequency. Given the return of cyp1a expression to control levels, one would 
assume that tissue PAHs were presumably eliminated by this point. However, at the end of exposure, cyp1a was 
not expressed in the cardiac tissues of haddock with an abnormal ventricular myocardium. While this may seem 
paradoxical (effects of PAHs in the absence of Cyp1a induction, the main indicator of the presence of strong AhR 
agonists in tissues), tricyclic PAHs that block cardiac ionic channels24 are poor inducers of Cyp1a. This suggests 
that specific cardiotoxic PAHs accumulating in ventricular myocardium are not as readily detoxified, as observed 
recently in olive flounder (Paralichthys olivaceous) embryos54, leading to effects that continue after Cyp1a expres-
sion decays. Alternatively, this delayed effect could represent mobilization of a pool of PAHs contained in the yolk 
mass as larvae from the low dose treatment absorbed yolk in the post-hatch stages, as described for other hydro-
phobic contaminants55. Along with prior studies demonstrating differential tissue distributions of individual 
PAHs in fish embryos15, these findings indicate that the toxicokinetics of PAH uptake and distribution are likely 
more complicated than previously appreciated. In conjunction with prior studies, our data suggest that individual 
PAHs within complex mixtures are differentially distributed in the embryo, with some PAHs being transported 
through the circulation to be metabolized in the liver, for example, with others accumulating in cardiac tissue 
and escaping liver detoxification. This likely reflects the uptake and circulatory pathways for PAHs in embryos, 
supported by the pattern of Cyp1a induction observed here. The bulk of uptake is likely to occur across the large 
surface area of the yolk sac, into the yolk sac sinus where circulation goes directly to the heart. This would give 
direct access of poor Cyp1a inducers to myocardial tissue and binding to molecular targets (i.e., ion channels) 
prior to delivery to the liver for metabolism. The stronger AhR ligands responsible for most of the Cyp1a inducing 
activity of crude oil do not have binding targets in the heart, and would thus bypass the heart to be delivered by 
the circulation to the liver, where they induce Cyp1a and are metabolized. This induction of Cyp1a in the liver by 
more potent AhR agonists hence would not serve to protect from cardiotoxic weak AhR agonists, because they 
have already bound their target in the heart.
Finally, most studies on ion channel gene transcription have focused on homeostasic regulation (i.e., in 
mature heart cells), and there is not always a clear link between mRNA and protein levels37. However, the few 
studies on transcriptional responses to pharmacological blockade demonstrated cognate up-regulation of genes 
Figure 8. Expression of genes involved in EC coupling and wnt11 in the larval exposure. (A) Expression 
of wnt11 in individuals at 9 dph. (B) Expression of wnt11 in pooled samples during larval exposure from 
1 dph to 18 dph for all exposure groups and control during early larval phase. (C) Expression of kcnh2, ncx1, 
cacna1c, serca2 and wnt11 in individuals at 9 dph. Collectively, only wnt11 varied significantly from control in 
individuals. †Individual with A/V block. Statistical significant difference from control is indicated by *p < 0.05 
and **p < 0.01.
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for voltage-gated sodium and pacemaker channels38,39. In addition, studies of cardiac and skeletal muscle devel-
opment generally show a strong correlation between increasing mRNA levels and functional ion channel proteins 
(e.g. refs 56 and 57). Thus, in the developing embryonic heart, it would be expected that the normal increase in 
mRNA level for kcnh2, for example, is tied to the continuous growth and addition of cardiomyocytes and assem-
bly of new functional ion channels. Here we did not observe compensatory up-regulation in any EC coupling 
genes in exposed haddock, with an opposite response observed for kcnh2 (potassium voltage-gated channel sub-
family H member 2) and ncx1 (sodium/calcium exchanger 1). Analysis of genetic mutations in kcnh2 in zebrafish 
identified two mutant phenotypes, a collapsed silent ventricle associated with complete loss of function32, and a 
partial AV block with normal chamber morphology attributable to a weaker mutant allele31. Our ventricular phe-
notypes mirror these two classes of zebrafish mutant alleles closely. Reduced numbers or size of cardiomyocytes 
alone in the small ventricle phenotype is unlikely to explain the reduced levels of kcnh2 and ncx1, because there 
was no effect on cacna1c and serca2. Moreover, despite the presence of chronic AV block in the larval exposure, 
there was no compensatory transcriptional response in EC coupling genes. This suggests that crude oil is acting 
through a dual mechanism by blocking both ion channel function24 and feedback to transcriptional regulation 
of ion channel genes. For example, regulation of sodium channel subunit genes was shown to be controlled by 
cytosolic Ca2+ levels38, thus, PAH related blockade of calcium channels24 could potentially disrupt a Ca2+ second 
messenger feedback mechanism controlling kcnh2 compensatory transcription. Surprisingly, there are few papers 
describing the normal transcriptional regulation of kcnh2, and none to our knowledge assessing the effects of Erg 
blockade on kcnh2 transcription.
The relationship between Ca2+ signaling and transcription of ion channel genes most likely reflects the 
recently characterized process of excitation-transcription (ET) coupling58. In ET coupling, the integration of 
extracellular signals with components of the EC coupling machinery is mediated through the phospholipase C/
inositol 1,4,5-triphosphate (IP3) pathway, with IP3 receptors acting as an additional channel for release of Ca2+ 
from the sarcoplasmic reticulum and nuclear envelope58. If cells utilize a contiguous pool of Ca2+ within the sar-
coplasmic reticulum and nuclear envelope, it is likely that depletion of this pool by crude oil-derived PAHs would 
impact both contractility and transcription.
Potential relationship between cardiac and craniofacial defects. The links between intracellular 
calcium pools that regulate contractility and signaling to the nucleus provide a likely mechanism for the spe-
cific craniofacial defects we observed. First, the severe phenotypes in embryonically exposed animals cannot be 
explained solely by impaired circulation. The craniofacial defects resemble zebrafish mutants affecting several dif-
ferent developmental pathways that depend on intracellular calcium and could thus be impaired by crude oil. This 
includes midline signaling pathways, such as Wnt11, Hedgehog and Nodal pathways59,60. Although there were no 
major changes in wnt11 mRNA levels in exposed embryos, the selective reduction of the basal neurocranium/pal-
ate (ethmoid plate) observed in the larval exposure may be connected to up-regulation of wnt11. However, palatal 
development involves signaling centers that utilize members of the fibroblast growth factor (FGF) family, Wnt 
family members in addition to Wnt11, as well as the planar cell polarity (PCP) pathway61–63. There are multiple 
avenues through which intracellular calcium impinges on these pathways, for example through phospholipase C 
(e.g., FGF receptors64), and both canonical Wnt and Wnt/Ca2+ signaling65–67. At the same time, there is a poten-
tial role for a Serca2 family member in midline signaling68. However, the expression of serca genes has not been 
described in detail in fish embryos, and serca genes were not expressed in neural crest cells in frog embryos69. In 
this light, it is intriguing that our craniofacial defects are also strikingly similar to those that arise from the lack 
of craniofacial muscle development or function70,71. Thus, abnormal formation of craniofacial cartilages could be 
secondary to effects of crude oil on the contractile apparatus of associated craniofacial muscles. Our findings in 
zebrafish embryos with total nominal oil load (and thus PAH concentrations) several orders of magnitude higher 
indicate that these craniofacial defects are specific to Gadids, and not due to a unique activity present in the 
Heidrun crude oil. Why these pathways are disrupted specifically in haddock remains to be determined, but most 
likely reflects differences in toxicokinetics, differential sensitivities of target proteins, or both.
Implications of oil droplet binding for exposure duration and timing. The results here confirm 
and extend our previous findings10 and highlight the unusual negative consequences of oil droplet binding to the 
haddock eggshell. Accordingly, early embryonic exposure of haddock leads to more severe toxicity than might be 
expected from previous studies on other species and the nominal exposure concentrations used here (0.7–7 μg/L 
∑PAH). This is emphasized by (1) the relatively severe effects of the pulse treatment, (2) defects arising from as 
little as 24 hours of transient early embryonic exposure, and (3) the differences between the embryonic and larval 
exposures, especially in regard to cyp1a induction.
The heterogeneity of phenotypes at a given oil concentration in the embryonic exposure probably reflects 
variability in internal dose due to variable accumulation of droplets, while the very uniform response in the larval 
exposure reflects primarily toxicity from dissolved PAHs. Both embryos and larvae were exposed to the same 
concentrations of oil droplets and dissolved PAHs, but peak cyp1a induction was 10-fold higher in embryos. 
Given that the single measurements for tissue PAH concentrations in embryos and larvae were close (only about 
2.5-times higher in embryos) and taken at the end of exposure, the much higher early peak of cyp1a expression 
suggests that embryos probably accumulated higher peak tissue concentrations of PAHs at those earlier time 
points. Cyp1a metabolism could be more effective in larvae, but comparison to other species also indicates that 
haddock embryos receive a higher effective dose due to droplet binding. For example, Pacific herring embryos 
exposed to dissolved PAHs accumulated even higher tissue levels and showed cardiac defects (bradycardia and 
arrhythmia), but not the severe craniofacial phenotypes or gross malformations evident in the HB phenotype 
observed here14. Likewise, mahi mahi (Coryphaena hippurus) embryos exposed to physically dispersed oil con-
taining total PAH of about 15 μg/L (oil droplets and dissolved combined) showed only cardiac defects and a 
www.nature.com/scientificreports/
1 6Scientific RepoRts | 6:31058 | DOI: 10.1038/srep31058
lower level of cyp1a induction (~40-fold), and did not appear to bind oil droplets27. These interspecies com-
parisons therefore provide additional evidence for specific targets of crude oil toxicity in haddock craniofacial 
development.
Our findings also reveal how oil droplet binding influences the toxic impacts relating to exposure duration and 
developmental stage. The phenotypes in the pulse group are consistent with higher peak tissue concentrations at 
key sensitive time points relative to the low group. Although this is not reflected in the temporal pattern of cyp1a 
induction or final tissue PAH concentrations, which were indistinguishable between pulse and low groups, it is 
likely that cyp1a induction reflects an average or integrated response. Therefore, shorter exposure to higher levels 
of dispersed oil in early developmental stages can have a greater impact than expected based on an average PAH 
concentration. More importantly, oil droplet binding leads to prolonged effective exposure from even very brief 
interactions with dispersed oil, indicated by the relatively severe effects of the 24- and 48-hr exposures. These 
findings are especially important for risk assessment modeling, indicating that effects on haddock cannot be pre-
dicted simply on measured water concentrations of either dissolved or total PAHs in oil droplets.
Conclusions
Our findings underscore the unique susceptibility of haddock embryos to dispersed crude oil toxicity as a likely 
consequence of oil droplet binding. Compounding this phenomenon, haddock show distinctive craniofacial 
malformations that could be linked to novel mechanisms of crude oil toxicity. In other species extracardiac mor-
phological defects are secondary to cardiotoxicity, either through AhR agonism or disruption of EC coupling (or 
both). The atypical nature of haddock craniofacial defects and the absence of AhR agonism in cardiomyocytes 
strongly suggest that crude oil is having a direct effect on craniofacial development (e.g., midline signalling) in 
haddock. This unusual teratogenic effect of crude oil potentially highlights an emerging role for calcium sign-
aling in midline and craniofacial development. Moreover, the negative effect of oil exposure on the expression 
of EC coupling genes is a newly identified mechanism of crude oil cardiotoxicity, most likely also involving the 
direct effects of tricyclic PAHs on ET coupling. Calcium signaling in development is complicated and challeng-
ing to dissect due to many interconnected roles in both excitable and non-excitable cells72,73. While oil-induced 
defects in heart development are simple to link to disruption of EC coupling, craniofacial defects could arise from 
disruption of calcium signaling in either excitable (e.g., skeletal muscle) or non-excitable cells (e.g., Wnt signaling 
in chondrocyte precursors). Moreover, ET coupling is only beginning to be characterized in detail58. Crude oil 
and specific compounds underlying the phenotypes observed here may be valuable tools for a greater understand-
ing of the many roles intracellular calcium plays in vertebrate development and cellular function.
Materials and Methods
Animal collection, maintenance and exposure set up. A wild haddock broodstock population of 
61 maturing individuals was collected February-March 2013 at spawning grounds in the Austevoll area, on the 
west coast of Norway, and kept in two outdoor 7000 L tanks at the Institute of Marine Research (IMR), Austevoll 
Research station. Haddock spawn voluntarily in captivity, and fertilized eggs could therefore be collected from 
the tanks, transferred to indoor egg incubators, and maintained at 7.8 °C until transmission to exposure tanks. 
At 2 days post fertilization (dpf) ~6000 eggs (embryonic exposure) and 13 dpf ~6000 eggs (larval exposure) were 
transferred into each of 16 circular exposure tanks (50 L) of green PE plastic (4 replicates for each treatment). The 
flow through the tanks was 32 L/hr, the water temperature 7.8 °C, and light regime was 12D:12L. Light for four 
replicate tanks was provided by the broad spectrum 2 × 36W Osram Biolux 965 (Munich, Germany, www.osram.
com) dimmable fluorescent light tubes with 30 min smooth transitions between light and dark. From four days 
post hatching (dph), natural zooplankton, mainly copepod nauplii of Acartia longiremis, was harvested from the 
marine pond system “Svartatjern”74 and introduced as feed to the larvae.
The tanks were further supplemented with marine microalgae concentrate (Instant Algae, Nanno 3600, Reed 
Mariculture Inc., CA, USA) until termination of the experiments75.
Oil exposure regime. The crude oil used was a weathered blend crude oil from the Heidrun oil field of the 
Norwegian Sea. The blend oil comes from 4 different formations that contain different oil types, both light par-
affinic oils (0.83 g/ml) and heavy biodegraded oil (0.93 g/ml) and is exported as a heavy crude oil (0.89 g/ml). The 
Heidrun blend oil is believed to be representative for the characteristics of oil that may be found in the Lofoten 
area. The oil is artificially weathered by distillation to account for the fast evaporation that normally occurs after 
an oil spill at sea. This procedure76 is a simple one-stage distillation to vapor temperatures of 250 °C leaving a 
residue that corresponds to 2–7 days on the sea surface at about 10 °C ambient temperature, in this case causing 
an evaporative loss of 24% of the lighter compounds from the fresh crude oil, and it changes the oil density from 
0.89 g/mL to 0.92 g/mL (SINTEF, 2004)77.
The principle of the exposure system and procedures for oil droplet generation are described in detail else-
where78. The oil was pumped into the dispersion system using a HPLC pump (Shimadzu, LC-20AD Liquid 
Chromatograph Pump) with a flow of 5 μl/min together with a flow of seawater of 180 mL/min. The system gen-
erates an oil dispersion with oil droplets in the low μm range with a nominal oil load of 26 mg/L (stock solution). 
The exposure dose to the tanks was regulated by a parallel pipeline system with one line of flowing clean seawater 
and the other line containing a flow of the stock solution. The 2 pipelines were connected by a 3-way magnetic 
valve allowing water to be collected from both lines. Different dilutions were made by controlling the relative 
sampling time from the oil stock solution and clean water, respectively. The experimental setup consisted of three 
treatments and a control, each with four replicates: 60 μg oil/L (low dose), 600 μg oil/L (high dose), 600 μg oil/L for 
2.4 hours in a 24 hour period (pulse dose), and no oil (control). The concentration of oil (measured PAHs) in the 
pulse tanks decreased to approximately zero before the next pulse (Supplementary Fig. S14). The oil dispersion 
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doses were given by opening the magnetic valve for 27 seconds every minute in the high treatment group and 3 
seconds in the low treatment group. The pulse treatment group received 27 seconds of oil stock solution every 
minute for 2.4 hours in each 24 hour period. Oil dispersions were delivered to each of the replicate exposure tanks 
at a flow rate of 30 mL/min and mixed into the main water supply of 500 mL/min. To avoid formation of oil film 
on the water surface in the tanks, an air valve was mounted in each tank to continuously blow air onto the water 
surface.
In the continuous embryonic exposure, the exposure was stopped after 7 days of exposure (10 dpf) and all sur-
viving embryos were transferred to 16 new tanks with clean seawater for further monitoring. The embryos started 
to hatch at 11–12 dpf and 50% hatch was observed at 13 dpf (=0 dph). Hatching success for the various groups 
were 82% ± 2 in control, 78% ± 4 in low dose, 70% ± 9 in pulse dose and 50* % ± 18 in high dose (*significant 
different from control p ≤ 0.05). In the transient embryonic exposure, an aliquot of 300 eggs from all tanks were 
transferred to four tanks (one for each treatment and control) with clean seawater after 24 and 48 hours of initial 
exposure (3 and 4 dpf, Supplementary Fig. S14). The transient embryonic exposure was terminated at 2 dph. For 
the larval exposure, the exposure started at 0 dph and was stopped after 18 days (18 dph).
Imaging of live embryos/larvae and measurements of cardiac function. Digital still micrographs 
of live larvae were obtained with an Olympus SZX-10 stereo microscope equipped with a 5 Mp resolution camera 
(Infinity 2–5c, from Lumenera) while video recordings where obtained using the same microscope and a Nikon 
SMZ-800, both with 1.2 Mp resolution video cameras (Unibrain Fire-I 785c). Image magnification was calibrated 
with a stage micrometer. BTV Pro 5.4.1 (www.bensoftware.com) was used to control the video camera. Video 
microscopy was performed at 1 and 3 dph (Continuous and Pulse embryo exposures, 60 larvae per treatment), 
2 dph (Transient embryo exposure, 30 larvae per treatment) and 3 and 9 dph (Larval exposure, 48 larvae per 
treatment). Animals were immobilized in a glass petri dish filled with 3% methylcellulose and kept at 8 °C using 
a temperature controlled microscope stage. Length of ethmoid plate, mandible, area of edema and length, area 
and circularity of ventricle were measured using ImageJ (ImageJ 1.48r, National Institutes of Health, Bethesda, 
Maryland, USA, http://rsb.info.nih.gov/ij) with the ObjectJ plugin (https://sils.fnwi.uva.nl/bcb/objectj/index.
html) from images as described in Fig. 5. At 0 dph for the embryonic exposure, the area occupied by edema fluid 
was quantified as the difference between the total area of the yolk sac and the area of the yolk mass, expressed 
as a percentage of total yolk sac area (Fig. 5). For larval exposure, we quantified edema accumulation at 9 and 
18 dph with a similar approach, as the difference between the area occupied by the internal organs and the total 
pericardial and abdominal area. The assessment of edema at 9 dpf was based on presence/absence, not estimated 
edema area. ImageJ was also used to measure the ventricular and atrial diastolic (D) and systolic diameter (S) to 
estimate the fractional shortening (FS = (D − S)/D) (Fig. 5A,B). Atrial beats per minute (BPM) were also counted. 
Measurements from both images and videos were performed blind.
To quantify oil microdroplets on the eggshell we recorded PAH associated blue fluorescence using a Nikon 
AZ100 microscope equipped with a DAPI filter set (peak excitation 330–380 nm; emission >425 nm) and a 
Nikon Intensilight C-HGFI fluorescence light source. Pictures were taken using a 2x objective and 1x zoom and 
a QICAM monochrome camera (1392 × 1040 pixels, http://www.qimaging.com) resulting in images with a reso-
lution of 0.237 pixels/μm. The microscope UV-light, camera exposure time and gain factor were initially adjusted 
to the high exposure group eggs so that oversaturation did not occure in the picture. These factors were then 
held constant (2 sec exposure time, gain 5) for all images. Each picture usually contained 6 eggs. Emission on the 
eggshell was estimated using Image J; each egg was encircled using the circular ROI (region of interest) tool and 
mean light intensity measured for each. If the eggshell had artifacts (e.g., small particles) that interfered with the 
measurement, these were excluded from the ROI before measurement.
Analytical chemistry. Water samples (1 L) were taken from each exposure tank at the beginning of each 
experiment, preserved by acidification (HCl, pH < 2) and stored at 4 °C in the dark until further handling. 
The samples were extracted twice by partitioning to dichloromethane (30 mL) in a separatory funnel (2 min). 
Deuterated internal standards (naphthalene-d8, biphenyl-d8, acenaphtylene-d8, anthracene-d10, pyrene-d10, 
perylene-d12 and indeno(1,2,3-c,d)perylene-d12) were added prior to extraction to account for analyte loss dur-
ing extraction. The combined extracts were concentrated by solvent evaporation prior to analysis by GC-MS. The 
following PAH compounds were measured: C0, C1-, C2-, C3-naphthalenes (N), anthracene (ANT), acenaphth-
ylene (AC), acenaphtene (AE), fluorene (F), phenanthrene (P), C1-, C2-, C3-phenanthrene/anthracenes (P/A), 
C0, C1-, C2-, C3-dibenzothiophenes (D), fluoranthene (FL), pyrene (PY), benzo[a]anthracene (BAA), chrysene 
(C), benzo[bjk]fluoranthene (BKF), benzo[e]pyrene (BEP), benzo[a]pyrene (BAP), perylene (PER), benzo[ghi]
perylene (BP), indeno[1,2,3-cd]pyrene (IND) and dibenzo[a,h]anthracene (DBA). The method is described in 
detail in10.
Pooled tissue samples of eggs (100 mg wet weight, corresponding to approximately 100 individuals) and larvae 
(100 individuals, approximately 200–250 mg wet weight) were collected at the final day of exposure. Duplicate sam-
ples were taken from each exposure tank, including controls. The samples were preserved by flash-freezing in liquid 
nitrogen and stored at −80 °C. Tissue samples were extracted by solid liquid extraction and purified by solid phase 
extraction prior to analysis by GC-MS/MS. The method is described in detail in Sørensen et al.79. Briefly, after addi-
tion of internal standards (100 ng/g naphthalene-d8, biphenyl-d8, acenaphtylene-d8, anthracene-d10, pyrene-d10, 
perylene-d12 and indeno(1,2,3-c,d)perylene-d12) the samples were homogenized in 2 mL dichloromethane-hexane 
(1:1, v/v), followed by addition of sodium sulphate (150 mg), vortex extraction (30 sec) and centrifugation (2000 rpm, 
2 min). The supernatant was collected and the extraction repeated twice more. The combined organic extract was 
concentrated to ~1 mL prior to clean-up by SPE (Agilent Bond Elut SI, 500 mg). The SPE columns were conditioned 
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with hexane and the extract eluted with 6 mL 10% dichloromethane in hexane. Immediately prior the analysis, the 
purified extract was concentrated to 100 μL under a gentle stream of N2.
RNA collection and preparation. Embryos (before hatching) and larvae (after hatching) were collected 
ten times from 3 dpf to 3 dph, in addition to an initial sample at 2 dpf. In the larval exposure seven samples were 
collected from 0 dph to 22 dph, in addition to an initial sample at 0 dph. For the transient embryo exposure, 
RNA samples were collected at the end of the experiment (2 dph). All animals collected for RNA extraction 
were imaged under a microscope before they were frozen in liquid nitrogen and stored at −80 °C. Two pools of 
embryos and larvae from each tank were collected at all sampling times for total RNA extraction. In addition 
individual larvae were sampled and preserved in RNAlater Stabilization Solution (Life Technologies Corporation) 
at 3 dph (embryonic exposure) and 9 dph (larval exposure).
Total RNA was isolated from frozen pools with varying amount of embryos (15–25) and pools of ten larvae 
using Trizol reagent (Invitrogen, Carlsbad, California, USA), according to procedures provided by the manu-
facturer which included a DNase treatment step using a TURBO DNA-free kit (Life Technologies Corporation). 
Total RNA from single larvae from 3 dph (embryonic exposure) and 10 dph (larval exposure) were extracted 
using RNeasy micro kit (QIAGEN Sample and Assay Technologies) according to procedures provided by the 
manufacturer. For both embryonic and larval exposure 12 larvae equally representative of each replicate tank 
analyzed were individually extracted. For the embryonic exposure, additional larvae with the hunchback or Darth 
Vader phenotype were extracted to verify if significant changes in gene expression of ncx1 and kcnh2 observed 
in the initial sample of 12 individuals were robust. All samples were homogenized in their respective lysis buffer 
2 × 20 seconds at 5000 rpm using a Precellys 24 apparatus (Precellys). The amount of RNA was quantified using 
a Nanodrop spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA), and quality checked using a 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). cDNA was subsequently generated using SuperScript 
VILO cDNA Synthesis Kit (Life Technologies Corporation), according to the manufacturer’s instructions. The 
cDNA was normalized to obtain a concentration of 50 ng/μL.
Real time qPCR. Specific primers and probes for real-time, qPCR analysis of Atlantic haddock, cyp1a and the 
technical reference ef1a and kcnh2, ncx1, serca2, cacna1c and wnt11 mRNAs were designed with Primer Express 
software (Applied Biosystems, Carlsbad, California, USA) and Eurofins qPCR probe and primer design software 
(Eurofins Scientific, Ebersberg, Germany), respectively, according to the manufacturer’s guidelines. Primer and 
probe sequences are given in Supplementary Table S3. TaqMan PCR assays were performed in duplicate, using 
384-well optical plates on an ABI Prism Fast 7900HT Sequence Detection System (Applied Biosystems, Carlsbad, 
CA, USA) with settings as follows: 50 °C for 2 min, 95 °C for 20 s, followed by a 40 cycles of 95 °C for 1 s and 60 °C 
for 20 s. Duplicates with standard deviation2 (SD2) ≤ 0.05 were either rerun or eliminated from the dataset. No 
template, no reverse transcriptase enzyme control and genomic DNA controls were included. For each 10 μl PCR 
reaction, a 2 μl cDNA 1:40 dilution (2.5 ng) was mixed with 200 nM fluorogenic probe, 900 nM sense primer, 
900 nM antisense primer in 1xTaqMan Fast Advanced Master Mix (Applied Biosystems, Carlsbad, California, 
USA). Gene expression data for kcnh2, ncx1, wnt11, cacna1c and serca2 in pools were calculated relative to the 
start sample (2 dpf and 1 dph for embryonic and larval exposure, respectively) using the ΔΔΔCt method gener-
ating reference residuals from ef1a (technical reference) and serca2 (biological reference) in the embryonic and 
larval exposure, as described in detail in Edmunds et al.80. While gene expression data from individuals at 3 dph 
(embryonic exposure) and cyp1a in pools was calculated relative to control or start point, respectively, using the 
ΔΔCt method as described in detail in Bogerd et al.81.
Cyp1a immunofluorescence. Haddock larvae were collected on the day of hatch initiation, one day 
after termination of exposure, fixed overnight in 4% paraformaldehyde buffered in PBS, then rinsed in PBS and 
transferred to methanol for storage. Whole mount labeling with anti-Cyp1a monoclonal C10-7 (cod antigen) 
and AlexaFluor 488-labeled anti-mouse IgG3 was carried out as described elsewhere and imaged on a Zeiss 
LSM-Pascal confocal system13. Twelve larvae from each treatment group were labeled and examined, with repre-
sentative images collected from three randomly selected individuals.
Histology. Six larvae from each replicate were pooled and fixed in 4% PBS buffered paraformaldehyde for 
24 hrs at 4.0 °C, processed using Histokinette 2000 (Reichert-Jung), and embedded in paraffin wax within three 
days to preserve the RNA and tissue morphology. Sample preparation was always performed under RNase free 
conditions. Serial sectioning (3 μm) of larvae was performed for morphological analysis or in situ hybridization 
using a Leica RM 225 microtome (Leica Microsystems).
For in situ hybridization (ISH), the Atlantic haddock cyp1a cDNA was amplified using PCR containing Sp6 and 
T7 primers in the forward and reverse primers, respectively (Cyp1a_FW_Sp6: 5′-ATTTAGGTGACACTATAGC 
AT C T T C C A G AT C C A G AT C G - 3 ′  C y p 1 a _ RV _ T 7 :  5 ′ - TA ATA C G A C T C A C TATA G G G C 
ATGAACCTCTTCATGGTGG-3′). The PCR product of 501 bp was used as a template for synthesizing the sense and 
antisense cRNA probes by the Sp6 and T7 RNA polymerase, respectively. The digoxigenin (DIG) labeling was per-
formed using the DIG-AP RNA labeling kit (Roche Molecular Biochemicals) following the manufacturers protocol.
The in situ hybridization was carried out as described by Weltzien et al.82 with some modifications83. 
Hybridization was always carried out with sense and antisense probes on adjacent sections, and under RNase 
free conditions.
Alcian blue staining. Three days post hatching, larvae from the embryonic exposure were fixed overnight 
in 4% PBS-buffered paraformaldehyde, rinsed in PBS and transferred to methanol for storage at −20 °C. After 
re-hydration, 20 larvae per treatment were stained with Alcian blue, dissected and imaged as described elsewhere21.
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Zebrafish exposures. Zebrafish embryos were collected from AB adult fish maintained as described else-
where21. A high-energy water accommodated oil fraction (HEWAF) of weathered Heidrun oil was prepared in 
zebrafish system water at 50 mg/L using a stainless steel commercial blender21. Embryos were exposed to whole 
HEWAF (containing oil droplets) in 100-mm glass petri dishes at a density of 2 embryos/mL beginning at ~50% 
epiboly to 72 hpf without renewal (three replicates of 80 embryos each for control and 100% HEWAF). Embryos 
were scored for gross abnormalities, pericardial edema and intracranial haemorrhage21 at ~48 hpf and craniofacial 
phenotypes at 72 hpf, with random embryos selected for imaging at 48 and 72 hpf using a Nikon SMZ-800 stere-
omicroscope with a Unibrain Firewire-800 camera (Fire-i 780c) and BTV Pro 5.4.1 software.
Statistics. Statistical analysis was performed with GraphPad Prism, version 6 (GraphPad Software Inc., 1996, 
La Jolla, California, USA). Significant differences in structural and functional measurements, phenotypic char-
acterization, PAH related fluorescence intensity on the eggshell and gene expression in individual samples were 
tested with one-way ANOVA using the Tukey-Kramer multiple comparison. Gene expression in pooled samples 
was analyzed using Two-way ANOVA, with Dunnet’s multiple comparison used in post-hoc tests in cases where 
there was a significant time-dose interaction. The level of significance was set at p < 0.05 unless otherwise stated.
Ethics Statement. All animal experiments within the study were approved by NARA, the governmental 
Norwegian Animal Research Authority (http://www.fdu.no/fdu/, reference number 2012/275334-2). All methods 
were performed in accordance with approved guidelines. All embryos sampled were frozen in liquid nitrogen. 
All larvae were euthanized using 500 mg/L MS-222 (Tricaine methanesulfonate, TS 222, Sigma-Aldrich) when 
sampling and at termination of the experiment to achieve immediate death. The animals were monitored daily, 
and any dead larvae were removed. The Austevoll Aquaculture Research station has the following permission for 
catch and maintenance of Atlantic haddock: H-AV 77, H-AV 78 and H-AV 79. These are permits given by the 
Norwegian Directorate of Fisheries. Furthermore, the Austevoll Aquaculture Research station has a permit to 
run as a Research Animal facility using fish (all developmental stages), with code 93 from the national IACUC; 
NARA.
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